Abstract
Nitric oxide (NO) has been pointed out as being the main mediator involved in the hypotension and tissue injury taking place during sepsis. This study aimed to investigate the cellular mechanisms implicated in the acetylcholine (ACh)-induced relaxation detected in aortic rings isolated from rats submitted to cecal ligation and perforation (CLP group), 6h post-CLP. The mean arterial pressure was recorded, and the concentration-effect curves for ACh were constructed for endothelium-intact aortic rings in the absence (control) or after incubation with one of the following NO synthase inhibitors: L-NAME (non-selective), L-NNA (more selective for eNOS), 7-nitroindazole (more selective for nNOS), or 1400W (selective for iNOS). The NO concentration was determined by using confocal microscopy. The protein expression of the NOS isoforms was quantified by Western blot analysis. The prostacyclin concentration was indirectly analyzed on the basis of 6-keto-prostaglandin F(1α) (6-keto-PGF(1α)) levels measured by enzyme immunoassay. There were no differences between Sham- and CLP-operated rats in terms of the relaxation induced by acetylcholine. However, the NOS inhibitors reduced this relaxation in both groups, but this effect remained more...Continue Reading
References
May 7, 1976·Analytical Biochemistry·M M Bradford
Jan 1, 1992·Journal of Cardiovascular Pharmacology·E NavaS Moncada
Apr 10, 1992·Science·Q W XieC Nathan
Jun 1, 1994·Archives of Biochemistry and Biophysics·E P GarveyI G Charles
Nov 1, 1994·Journal of Cardiovascular Pharmacology·S J ChenM H Yen
Nov 10, 1995·The Journal of Biological Chemistry·M ColasantiH Suzuki
Jul 1, 1993·Circulation Research·M YoshizumiM E Lee
Jun 21, 1996·The Journal of Biological Chemistry·U A ArnetC J Lowenstein
Jun 15, 1996·Nucleic Acids Research·J R MatthewsR T Hay
Sep 15, 1996·Virology·M BarnaC S Reiss
Oct 1, 1996·Shock·A VromenC Szabó
Feb 21, 1997·The Journal of Biological Chemistry·E P GarveyR G Knowles
Mar 27, 1997·Biochimica Et Biophysica Acta·Y KakuM Ikeda
Aug 4, 1997·FEBS Letters·M BucherA Kurtz
Nov 24, 1999·Clinical and Experimental Pharmacology & Physiology·P Chamiot-ClercJ F Renaud
Jul 13, 2000·Critical Care Medicine·A B Groeneveld, P Sipkema
Dec 7, 2002·Hypertension·Klaus HöcherlMichael Bucher
Sep 5, 2003·European Journal of Pharmacology·Arnaud MansartJean-Pierre Mallié
Jan 24, 2006·Journal of Smooth Muscle Research = Nihon Heikatsukin Gakkai Kikanshi·Ednir O VizioliAgnaldo B Chies
Jul 4, 2006·The Journal of Pharmacology and Experimental Therapeutics·Salvatore CuzzocreaDaniela Salvemini
Jul 9, 2008·Hypertension·Klaus HöcherlMichael Bucher
Jun 6, 2009·Journal of Internal Medicine·M Rosas-Ballina, K J Tracey
Sep 17, 2009·Journal of Cardiovascular Pharmacology·Jaganathan SubramaniSantosh Kumar Mishra
Dec 21, 2010·Vascular Pharmacology·Alice V AraújoLusiane M Bendhack
Jan 18, 2011·Bulletin of Experimental Biology and Medicine·P F Zabrodskii
Citations
Sep 12, 2013·BioMed Research International·S OmanwarM Fahim
Aug 9, 2015·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Karin ScheschowitschJamil Assreuy
Oct 20, 2006·Pulmonary Pharmacology & Therapeutics·Shi-Jye ChuKun-Lun Huang
Sep 19, 2012·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·Mara R N CelesMarcos A Rossi
Mar 22, 2020·International Journal of Molecular Sciences·Itaynara L DutraAfonso G Abreu
Feb 2, 2021·Frontiers in Physiology·Daniela Esteves Ferreira Dos Reis CostaDaniella Bonaventura
Oct 23, 2020·Life Sciences·Shupeng HuYong Xia
Jan 7, 2019·Nitric Oxide : Biology and Chemistry·Natália NóbregaDaniella Bonaventura